OverviewSuggest Edit

Hua Medicine (华领医药) is a drug development company. It focuses on therapies for the treatment of diabetes and CNS disorders. The company develops an oral drug for the treatment of type 2 diabetes.

TypePublic
Founded2011
HQShanghai, CN
Websitehuamedicine.com
Overall CultureB+

Latest Updates

Employees (est.) (Dec 2019)158(+38%)
Share Price (Jun 2021)$4.8(-1%)
Cybersecurity ratingAMore

Key People/Management at Hua Medicine

Li Chen

Li Chen

Founder and CEO, Executive Director
Robert T. Nelsen

Robert T. Nelsen

Chairman
George Lin

George Lin

EVP & Chief Financial Officer, Executive Director
Daniel Du

Daniel Du

SVP, Regulatory, Medical Safety and Manufacture
Yi Zhang

Yi Zhang

Sr. VP, Pharma. Development, CMO China
Lian Yong Chen

Lian Yong Chen

Non-Executive Director
Show more

Hua Medicine Office Locations

Hua Medicine has offices in Shanghai, Beijing, Wuhan and Hong Kong
Shanghai, CN (HQ)
No.275 Ai Di Sheng Road, Zhangjiang Hi-Tech Park, Pudong
Beijing, CN
Room 7C12, Building 2, Courtyard No.1, Xizhimenwai Street, Xicheng District
Wuhan, CN
Rm2504B, 2505B,25th floor, Yuexiu Fortune Center, No.1 Zhongshan Avenue, Qiaokou District
Hong Kong, HK
Methodist House, 36 Hennessy Rd, Wan Chai
Show all (4)

Hua Medicine Financials and Metrics

Hua Medicine Revenue

Market capitalization (4-Jun-2021)

4.6b

Closing stock price (4-Jun-2021)

4.8
Hua Medicine's current market capitalization is $4.6 b.
Show all financial metrics

Hua Medicine Cybersecurity Score

Cybersecurity ratingPremium dataset

A

91/100

SecurityScorecard logo

Hua Medicine Online and Social Media Presence

Embed Graph

Hua Medicine Company Culture

  • Overall Culture

    B+

    86/100

  • CEO Rating

    A+

    100/100

  • Compensation

    A+

    100/100

Learn more on Comparably

Hua Medicine News and Updates

Hua Medicine Successfully Completes SEED (HMM0301), Dorzagliatin’s Phase III Monotherapy Trial

SHANGHAI, China, June 18, 2020 (GLOBE NEWSWIRE) -- Hua Medicine (the “Company”, Stock Code: 2552.HK), a leading innovative drug development company focused on developing novel therapies for the treatment of diabetes, today announced topline results from SEED (also known as HMM0301), the first Phas…

Hua Medicine Selected for Inclusion in the MSCI Hong Kong Micro Cap Index

SHANGHAI, China, May 31, 2020 (GLOBE NEWSWIRE) -- Hua Medicine (the “Company”, Stock Code: 2552. HK), a leading innovative drug development company focused on developing novel therapies for the treatment of diabetes, is pleased to announce that the Company has been officially included as a constit…

Hua Medicine Announces 2019 Annual Results

Pivotal Phase III Trial Achieved Clinical Efficacy Endpoint at 24 WeeksDorzagliatin-Driven Portfolio Expands

Hua Medicine appoints Dr. Fuxing Tang, a former U.S. FDA Officer, as Chief Technology Officer

SHANGHAI, China, Feb. 13, 2020 (GLOBE NEWSWIRE) -- Hua Medicine, a leading clinical stage biotechnology company based in Shanghai, is pleased to announce that Dr. Fuxing Tang has joined Hua Medicine as Chief Technology Officer, VP of Formulation R&D and Product Development. He will also head u…

Hua Medicine to Release Phase III 24-Weeks Topline Data of Dorzagliatin Monotherapy Trial (HMM0301) on November 12

SHANGHAI, China, Nov. 08, 2019 (GLOBE NEWSWIRE) -- Hua Medicine (HKEX: 2552), a Shanghai-based drug development company focused on developing a global first-in-class oral drug for the treatment of type 2 diabetes, today announced that 24-week topline data of dorzagliatin’s monotherapy trial (HMM03…

Hua Medicine – Business & Pipeline Update

SHANGHAI, China, June 04, 2019 (GLOBE NEWSWIRE) -- Hua Medicine (HKEX: 2552), announced today our updated pipeline regarding our core technology targeting glucose homeostasis and first product, a glucokinase activator dorzagliatin (HMS5552).
Show more

Hua Medicine Frequently Asked Questions

  • When was Hua Medicine founded?

    Hua Medicine was founded in 2011.

  • Who are Hua Medicine key executives?

    Hua Medicine's key executives are Li Chen, Robert T. Nelsen and George Lin.

  • How many employees does Hua Medicine have?

    Hua Medicine has 158 employees.

  • Who are Hua Medicine competitors?

    Competitors of Hua Medicine include SiNatur, Retinset and Concenter BioPharma.

  • Where is Hua Medicine headquarters?

    Hua Medicine headquarters is located at No.275 Ai Di Sheng Road, Zhangjiang Hi-Tech Park, Pudong, Shanghai.

  • Where are Hua Medicine offices?

    Hua Medicine has offices in Shanghai, Beijing, Wuhan and Hong Kong.

  • How many offices does Hua Medicine have?

    Hua Medicine has 4 offices.